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The effects of two chemically different interferon in-
ducers on the suppression of atherosclerosis were studied
in rabbits fed an atherogenic chow diet. One group (10
rabbits per group) was fed normal rabbit chow, and
three groups were fed an atherogenic chow. One of the
latter groups received the atherogenic feeding alone; the
other two were treated with either polyinosinic-polycy-
tidylic acid (poly I:C) or 2-amino-5-bromo-6-phenyl-4-
pyrimidinone (ABPP). Neither of the drugs reduced sig-
nificantly the hypercholesterolemia induced by the feed-
ing. However, both poly I:C and ABPP treatment signif-
icantly reduced the percent area of the aortic intimal sur-
face lesions, stained for lipid with Sudan IV, compared
with that in untreated rabbits fed atherogenic chow.
The pathogenesis of atherosclerosis IS charactenzed by the
proliferation of cells in the intima and the focal accumulation
of lipid and connective tissue (1). Although elevated serum
cholesterol IS considered to be a major factor in the devel-
opment of the disease, several effective antlatherogemc agents
that are not aimed at lowering serum cholesterol have been
descnbed Most of these, such as rufedipme (2), diphos-
phonates (3) and lanthanum (4), act by mhibinng the calcium
overload m artenal cells of cholesterol-fed rabbits How-
ever, suppression of expenmental atherosclerosis m rabbits
was also achieved With an antiprohferative drug, colchicme
(5), and ItS derivative Dernecolcme (Colcermd) (3) Inter-
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Microscopic sections of typical aortic plaques showed
that both drug treatments significantly reduced the size
and number of intimal lipid deposits compared with those
observed in the aortas of untreated animals. Chemical
analysis for cholesterol and collagen content revealed
that interferon-inducing agents significantly reduced
cholesterol deposits in the aorta, with little effect on
fibrous protein deposition. The results indicate that two
unrelated interferon-inducing drugs suppressed ather-
ogenesis without reducing serum cholesterol and low
density lipoprotein levels. Whether the protection against
atherosclerosis is exerted by endogenous interferon pro-
duction remains to be determined.
feron IS being used to suppress abnormal cellular prohfer-
ation in the treatment of mahgnant diseases (6). Hypoth-
esizing that the atherogenic mechanism might be Similar to
neoplastic activity, we mitiated studies to examine the pos-
sibility of using interferon or ItS inducers as antiatherogemc
agents
Interferons are glycoprotems produced by many types of
cells m response to induction by a chemically diverse group
of agents, and exhibit a variety of antiviral, anticancer and
immunomodulatory activities (7) We report on treatment
with two chemically unrelated interferon inducers a high
molecular weight synthetic polynucleotide, polymosmic-
polycyndyhc acid (poly I C) (8), and a low molecular weight
pynnudine denvative, 2-ammo-5-bromo-6-phenyl-4(3H)-
pynrrudinone (ABPP) (9), which suppress aortic cellular
proliferation and lipid deposition in the cholesterol-fed rab-
bit, Without reducmg the dietary-mduced hypercholester-
olemia
Methods
Animals and diet. Forty young adult male New Zealand
white rabbits weighing 2 to 2 5 kg were assigned randomly
to four groups of 10 rabbits each One group received a diet
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of Punna rabbit chow (normal diet) The other three groups
received a fibrogemc-atherogemc diet (10)
Experimental procedure. One group of 10 rabbits was
fed the atherogemc diet without drug treatment (no drug
group) The second group was treated with poly I.C (P-L
Biocherrucals, Inc) once a week by Intravenous mjection
(100 JLg/kg body weight) Into the marginal ear vein The
synthetic double-stranded nbonucleic acid (RNA) (poly I C)
was reconstituted at a concentration of 1 mg/ml In stenle
phosphate-buffered sahne solution, pH 7 0 (0 006 M sodium
phosphate, 0 15 M sodium chlonde) and allowed to re-
anneal by heating In a 50°C water bath until dissolved and
then standing at room temperature to cool The third group
was treated WithABPP (The Upjohn Company) once a week
by mtrapentoneal Injection in doses of 200 mg/kg body
weight ThIS drug was adrmrustered as a suspension In 5
ml stenle phosphate-buffered sahne solution USIng a two-
synnge technique to generate and dehver the suspension
Body weight and food consumption were recorded and
fastmg blood samples were collected at the begmmng of the
study and after 4 and 8 weeks of the diet treatment for the
deterrrunation of total cholesterol by the Techmcon AAII
automated Liebermann-Burchard method as descnbed m the
Lipid Research Climes Program Manual (11) Lipoproteins
were separated from serum by sequential ultracentnfugation
(12). Serum interferon titers were determined by a vesicular
stomatitis VIral plaque reduction assay on pnmary rabbit
kidney cells (13)
Postmortem studies. The rabbits were killed after 9
weeks and the whole aorta from the aortic valve to the iliac
bifurcation was removed from each ammal. The aorta was
opened longitudinally along ItS antenor wall, and the ad-
venuna and adhenng adipose tissue were removed The
vessel was fixed and stained grossly WIth Sudan IV (14) to
visualize the hpid-nch atherosclerotic lesions After tracing
on an overlaid clear plastic sheet, the aortic surface area
and ItS hpid-stammg lesions were quantitated by an elec-
tromc graphics calculator (model 1223, Numomcs Corp )
Before stammg, small samples of aortic tissue were taken
from three areas of each aorta. proximal to the left subcla-
vian artery, mcluding the fifth Intercostal artenes, and distal
to the ongm of the celiac trunk The sample from the tho-
raCIC aorta was freeze-sectioned and stained With 011 red 0
for neutral hpid The other two samples of aortic tissue were
embedded In paraffin, sectioned and stamed routinely With
hematoxyhn-eosm, Masson's-tnchrome stain for collagen
and Verhoeff-Van Giesen' s stain for elastin Sections from
three areas of each paraffin block were used to quantitate
lesion areas WIth a ZeISS VIdeo-Plan morphometnc analysis
system ThIS analysis was performed bhndly to avoid sub-
jectrve bias
Assays. Biochemical analysis of the total cholesterol
content of the whole aorta was performed on duplicate ali-
quots of the total hpid extract (15) of the freeze-dned tissue
Total aortic collagen content was determined by measunng
the hydroxyproline content in duphcate USIng a colonmetnc
method (16) The statistical significance of intergroup dif-
ferences was determined by one-way analysis of vanance
USIng the Student-Newman-Keuls procedure for pair-wise
compansons (17)
Results
Serum lipids. There were no significant differences In
the average food consumption and weight gam between the
normal control group and the expenmental groups of rabbits
In the rabbits fed the atherogemc diet, the concentration of
total serum cholesterol increased from the normal levels to
atherogemc levels whether or not mterferon-mducmg drugs
were admmistered. The mean total serum cholesterol values
(mg/IOO ml) for each group after 8 weeks of feeding were
43 ± 15 (mean ± standard deviation) m the normal diet
group, 3,270 ± 873 m the untreated cholesterol-fed group
and 2,709 ± 970 and 2,580 ± 899 in the cholesterol-fed
groups treated With poly I C and ABPP, respectively (Fig
1) The elevated serum cholesterol was due to elevated levels
of cholesterol In very low density, Intermediate density and
low density lipoprotein fractions Increases m serum tn-
glycende levels In the rabbits fed the atherogemc diet were
smaller than those of serum cholesterol and were confined
to very low and Intermediate density hpoprotem fractions
There was no significant Increase In low density hpoprotem
tnglycende content
Interferon levels. Serum Interferon levels (3 hours after
mjection) averaged 351 ± 29 umts/ml in rabbits treated
WIth poly I C for 8 weeks compared WIth an average of 698
± 28 umts/ml after the first Injection ThIS result indicated
Figure 1. Mean total serum cholesterol levels m rabbits receivmg
the atherogenic diet (AD) With or Without one of the interferon-
mducmg drugs, poly I C (polymosimc-polycyndyhc acid) or ABPP
(2-ammo-5-bromo-6-phenyl-4-pynmldmone), for 8 weeks The bars
indicate the mean values for each group NS = not significant
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that the weekly spacing of the mjections had rather good
success m overcoming the development of hyporeactrvity
(9) No comparable interferon data were obtained for ABPP
because of the slow interferon response of this drug when
injected mtrapentoneally (18)
Macroscopic findings. Figure 2 shows representative
tracings of one aorta from each group Rabbits fed the ath-
erogemc dret without drug treatment developed widespread,
grossly visible atherosclerosis Portions of both the thoracic
and abdominal aortic surfaces and almost the entire aortic
arch were covered with hpid-stammg lesions The percent
of the mtimal surface affected by lesions was reduced sig-
mficantly by both poly I C treatment and ABPP treatment
(probability [p] < 0 05) compared with that m the untreated
atherosclerotic group The fatty lesions mvolvmg the ab-
dommal and thoracic aorta appeared to be reduced in both
number and Size, while the aortic arch lesions were more
resistant to suppression There was no significantdifference
m the reduction or distnbution of the lesions between the
two drug-treated groups
Biochemical results. Aorta from rabbits fed the ather-
ogemc diet contamed sigruficantly more (p < 0 001) cho-
lesterol than aorta from the normal diet group (Table I)
Treatment with either poly I C or ABPP resulted m a highly
significant reduction (p < 0 001) m the cholesterol accu-
rnulation m the aorta The reduction m aortic cholesterol
accumulationwas not significantlydifferent between the two
drug-treated groups The Increase in collagen content and
dry weight observed m rabbits fed the atherogemc diet was
not significantly affected by drug treatment
Microscopic findings. Microscopic exarnmation of fro-
zen sections of thoracic aorta stamed With 011 red 0 for lipid
revealed that compared With normal aorta (FIg 3A), sec-
Figure 2. Tracings of aorta from rabbits that received either a
normal diet or the atherogenic diet with or Without one of the
mterferon-mducmg drugs The black areas represent Sudan IV-
positive lipid lesions The mean (± standard deviation) surface
area covered m each group IS shown below each representative
tracmg *p < 0 05
Table 1. Effect of Interferon-Inducer Treatment on Cholesterol
Accumulation, Collagen Content and Dry Weight of Aorta in
Rabbits Fed an Atherogenic Diet
Cholesterol Collagen Hydroxyproline
(rng/aorta per kg (rng/aorta per kg Dry Weight
Group body weight) body weight) (rng)
Normal diet 008 ± 004 159 ± 031 014 ± 003
Atherogenic diet, 104±024 190 ± 043 021 ± 005
no drug
Atherogenic diet, 039 ± 026* 194±050 017±007
poly I C
Atherogenic diet. 043 ± 026* 196 ± 036 020 ± 003
ABPP
*p < 0 001 compared WIth atherogenic diet, no drug ABPP = 2-
ammo-5-bromo-6-phenyl-4-pynmldmone, poly I C = polymosimc-poly-
cytidyhc acid
nons from untreated, cholesterol-fed rabbits (FIg 3B) ex-
hibited a markedly raised Intima With large prohferations
of lipid-laden "foam" cells and some derangement of the
mtimal-medial elastin layers In rabbits treated WIth either
of the two interferon mducers (Fig 3C and D), the lesions
consisted of fewer layers of mnmal foam cells overlying an
otherwise normal artenal wall
Morphometric analysts of the lesion area as a percent of
the total artenal wall area (mtima plus media) and deter-
mmation of the frequency distribution of the lesion size
(Table 2) supported the findings of the gross morphologic
and biochemical studies In both the poly I.C- and ABPP-
treated groups of rabbits, the lesion area as a percent of the
total vessel wall area was significantly less compared WIth
that of untreated rabbits recervmg the atherogemc diet Fre-
quency distrtbution analysis of lesion size revealed that both
drug-treated groups had sigmficantly fewer large lesions (>
20% of total vessel area) m comparable areas of aorta than
did the nontreated atherosclerotic control group
Discussion
Normal
control
0%
Atherogenic Atherogenic Atherogenic
control + Poly I C + ABPP
.
'.'
.'
37±15% 20±9%* 19±13'/'*
The use of mterferon-mducmg agents circumvents many
of the hrmtatrons inherent m the production and rsolation
of species-specific interferons In tlus study, we used two
chemicallydissmnlar inducers poly I C, a synthetic double-
stranded RNA well known to be a potent inducer of rabbit
interferon (8), and a newly developed low molecular weight
pynrrudme denvatrve, ABPP (9), which induces high levels
of serum interferon III several different species (18) The
data presented in this report mdicate that both of these drugs
were effective m suppressing the prohferation of hpid-Iaden
foam cells and cholesterol deposits in aortic atherosclerotic
plaques m rabbits
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Figure 3. Histologic section through thoracic aorta stained with hematoxylin-oil red O. A, Normal
control rabbit. B, Typical aortic plaque from a rabbit fed the atherogenic diet alone. C and D,
Representat ive aort ic plaques from rabbits fed the atherogenic diet and treated simultaneously with
poly 1:C or ABPP , respectively. Areas of lipid deposition in intimal and subintimal cells appear
black . Scales are 100 Mm.
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Table 2. Morphometnc Analysis of Intimal Lesions
Lesion Area Frequency ot
as % Lesion Lesions > 200/, of
Group + Medra Area Total Vessel Area
Normal diet 1 8 ± 05 0
Atherogemc diet, 26 0 ± 32 65
no drug
Atherogenic dret, I 3 ± 30* 5*
poly I C
Atherogemc diet, 12 7 ± 3 4* 15*
ABPP
*p < 0 005 compared WIth atherogemc diet, no drug Abbrevrations
as In Table I
Antuuherogenic Mechanisms of Interferon Inducers
Suppression of initiation or suppression of athero-
genesis? The response to injury hypothesis of atherogenesis
( I) suggests that endoth elial injury may lead to desqua-
matron , platelet adherence , aggregation and release of plate-
let constItuents followed by prohferation of cells In the
artenal mtima The sources of imtial injury may Include
chrome hypercholesterolerrua as well as immunol ogic ,
hemodynamic , mecharncal and chemical factors The mono-
clonal hypothesis of athero genesis (19) maintains that, like
benign smooth muscle tumors of the uterus, the prohferating
cells of atherosclerotIc plaques may denve from monoclon al
growth of vascular smooth muscle cells It IS not possible
to determine from the present data whether the Interferon
inducers are acting to suppress the minanon or the pro-
gression of the prohferanve phase of atherogenesis
Effect on plasma cholesterol and lipoprotein. The
adrmrustranon of human leukocyte Interferon has been re-
ported to have profound effect s on the metabolism of plasma
hpoprotems In human subjects (20), lowenn g the plasma
level of tot al cho les terol. very low density Irpoprotein cho -
lesterol and apohpoprotem A-I However. the suppression
of aornc atherosclerosis observed In our study does not
appear to have been achieved by reduction of the expen-
mentally Induced hypercholesterolemia Hypertension also
IS a powerful atherogenic factor and Interferon and ItS in-
ducers are known to cause transient hypotension and pyrexia
after mjection (6.7) Although blood pressure and temper-
ature were not monitored In this study, It IS unlikely that a
blood pressure-lowenng effect IS an Important contn butmg
mechanism because the mjections of the Interferon Inducers
were spaced at weekly Intervals Another pOSSIbIlIty IS that
the drugs Interfere WIth the binding and uptake of choles-
terol-nch lipoproteins However , under condmons of ele-
vated serum cholesterol, the express ion of high affinity. low
density lipoprotem receptors on the surface of normal endo-
thehal and smooth muscle cells would be suppressed and
thus any possible drug Interference would be negligibl e In
addition, unpublished results from our laboratory indicate
that interferon has no effect on the uptake of normal or
modified low density hpoprotem by monocyte-deri ved
macroph ages
Suppression of intimal cellular proliferation. The data
strongly suggest that the rnechamsm of the present approach
to reduce rabbit aortic atherosclerosis IS related to suppres-
sion of innmal cellul ar proli feration by endogenous inter-
feron Clearly, the pOSSIbIlIty that suppression of the ath-
erosclerosis observed In this study may be mediated by
mterferon-rndependent mechanisms cannot be ruled out at
this time Indeed. ABPP has been shown to enhance natural
killer cells. cytotox ic macrophag es and antibody production
(2 1), while poly 1 C has an adjuvant effect on Immunolo gic
reacnvity (22) Whether this atheroscl erosis suppression can
be attnbuted directly to Interferon IS being mvestigated In
our laboratory by studies employmg punfied rabbit Interferon
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